Introduction
Tubulointerstitial inflammation and fibrosis play important roles in the progression of chronic kidney disease (CKD) and are closely associated with the prognosis of kidney diseases [1] [2] [3] . Transforming growth factor-β1 (TGF-β1) is one of the most important cytokines that participate in tubulointerstitial inflammation and fibrosis. It has been demonstrated that chemokines, including monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), are closely related to tubulointerstitial lesions [4] [5] [6] [7] . Peroxisome proliferator-activated receptor-γ (PPAR-γ), a member of the ligand-activated transcription factor superfamily, is expressed in many organs, including the kidney [8, 9] . In our previous study, we demonstrated that PPAR-γ could counteract the profibrogenic effects of TGF-β1 in the kidney [10, 11] . Furthermore, it has been found that activation of PPAR-γ has anti-inflammatory effects in inflammatory arrest and synchronize cell growth. After the 24 h, cells were treated with TGF-β1 (R&D Systems, Minneapolis, MN) at different concentrations (0, 0.5, 1, 2, 5, and 10 ng/mL) for 24 h or treated with 5 ng/mL TGF-β1 for different time intervals (0, 2, 6, 12, 24, 36, and 48 h). Cells were then harvested for further experimentation.
RT-PCR and real-time RT-PCR Total RNA was isolated from HK-2 cells using the TRIzol reagent (Invitrogen) according to the manufacturer's protocol. The RNA was eluted with RNase-free water. Reverse transcription was performed using a standard reagent (Promega) according to the manufacturer's protocols. Real-time PCR amplification was performed using the SYBR Green master mix (Toyobo, Japan) and the Opticon 3 Real-time PCR Detection System (Bio-rad). Cycling conditions were 94 °C for 5 min followed by 44 cycles of 94 °C for 15 s and 60 °C for 1 min. A final extension at 72 °C for 10 min was performed after the cycles were completed. Primers for amplifying GAPDH, MCP-1 and IL-8 were designed using Primer software and validated for specificity. Primer sequences are summarized in Table 1 . Relative amounts of mRNA were normalized to GAPDH levels and calculated using the delta-delta method from the threshold cycle numbers. Levels in the control experiments were set to 1, and all the other values are expressed as multiples thereof.
Enzyme-linked immunosorbent assay Commercial ELISA kits (Biosource, USA) were used to detect the level of MCP-1 and IL-8 in the supernatant of HK-2 cells according to the manufacturer's protocol.
Statistical analysis All values are expressed as the means±SD. Statistical analyses were performed using SPSS for Windows 11.0 (SPSS, Inc, Chicago, IL, USA). Statistical analyses between two groups were assessed by t-test. Statistical analyses among groups were assessed by ANOVA. P-values <0.05 were considered to be statistically significant. When HK-2 cells were treated with different concentrations of TGF-β1 for 24 h, the level of MCP-1 mRNA increased above basal levels with 2 ng/mL, peaked with 5 ng/mL and decreased with 10 ng/mL of TGF-β1, which corresponded to 1.64-, 2.65-, and 1.95-fold increases in MCP-1 mRNA levels, respectively ( Figure 1A ). When HK-2 cells were treated with 5 ng/mL of TGF-β1 for different time periods, MCP-1 mRNA expression increased at 6 h, peaked at 12 h and decreased after 24 h. No significant difference in MCP-1 expression was found at 36 h between the TGF-β1-treated and control groups (P>0.05, Figure 1B ).
Results

Dose
When HK-2 cells were treated with different concentrations of TGF-β1 for 24 h, IL-8 mRNA levels increased with 1 ng/mL, peaked with 5 ng/mL and decreased with 10 ng/mL of TGF-β1 ( Figure 2A ). Treatment of the HK-2 cells with 5 ng/mL of TGF-β1 increased IL-8 mRNA levels by 2.64 fold at 12 h (P<0.01) and by 2.19 fold at 48 h (P<0.01) ( Figure  2B ). Table 2 and Table 3 ).
Effects of TGF-β1 on MCP-1 and IL-8 protein levels in HK-2 supernatants
Discussion
Tubular epithelial cells play an important role in tubulointerstitial fibrosis by secreting cytokines and extra-cellular matrix. TGF-β1, which has a wide spectrum of biological functions, is one of the most important cytokines in this process. Recent studies suggest that chemokines, such as MCP-1 and IL-8, are closely associated with kidney diseases, and tubular epithelial cells are the predominant secretors of these chemokines [17, 18] . MCP-1 and IL-8 cause tubulointerstitial lesions by recruiting target cells, which include All experiments were performed in triplicate, and each sample was tested by two ELISA wells. All experiments were performed in triplicate, and each sample was tested by two ELISA wells. macrophages/monocytes, T cells, neutrophils, eosinophils and basophils, into the tubulointerstitium, where the target cells secrete cytokines, including TGF-β1 and TNF-α [19] [20] [21] [22] . However, recent studies on TGF-β1-induced chemokine secretion by tubular epithelial cells had contradictory results. Gerritsma JS and colleagues demonstrated that TGF-β1 increased the level of IL-8, but decreased the level of MCP-1 [23] . However, in a study published by Qi et al, IL-8 and MCP-1 expression was upregulated after TGF-β1 treatment [24] .
In our previous studies, we demonstrated that TGF-β1 increased ECM synthesis in renal interstitial fibroblasts [25] . However, it is not clear whether TGF-β1 recruits inflammatory cells and leads to their infiltration into the tubulointerstitium by upregulating cytokine secretion. In the current study, we investigated the expression of MCP-1 and IL-8 in HK-2 cells after stimulation with TGF-β1. Our results showed that HK-2 cells expressed basal levels of MCP-1 and IL-8, which agrees with results from previously published studies [26, 27] . In this study, we demonstrated that TGF-β1 upregulated the expression of MCP-1 and IL-8 in HK-2 cells. Our results from this study are consistent with our previous studies that demonstrated that TGF-β1 had proinflammatory and profibrogenic effects on HK-2 cells. Our results are also consistent with the study, for example, published by Qi and colleagues [24] . Recent studies suggest that increased expression of MCP-1 is found in several renal diseases [20, 21] , supporting the concept that TGF-β1 upregulates expression of MCP-1 in tubular epithelia. In the studies published by Gerritsma et al and Qi et al [23, 24] , the expression of IL-8 in tubular epithelial cells was upregulated after 48 h or 72 h of TGF-β1 stimulation. Their results are similar to our findings, suggesting that secretion of MCP-1 and IL-8 by tubular epithelial cells plays an important role in tubulointerstitial fibrosis and lesion formation [24] . PPAR-γ is a member of the ligand-activated transcription factor superfamily, which participates in a wide range of biological activities, including cell differentiation, fat metabolism, glucose metabolism, immune response regulation, inflammation, cell apoptosis and tumorigenesis [28, 29] . PPAR-γ had some anti-inflammatory effects on inflammatory bowel disease and rheumatoid arthritis [30, 31] . It ameliorates the inflammatory cell infiltration and downregulates the proinflammatory cytokine expression in animal models of diabetic nephropathy and lupus nephropathy as well as in mesangial cells, fibroblasts and tubular epithelial cells [32, 33] . Li and colleagues demonstrated that eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could downregulate LPS-induced MCP-1 expression via the PPAR-γ pathway [34] . In this study, we demonstrated that treatment with either 15d-PGJ2 or TGL counteracts the TGF-β1-induced MCP-1 and IL-8 expression. These findings suggest that PPAR-γ has an inhibitory effect on MCP-1 expression. Our results are similar to those reported by Zafiriou et al, who demonstrated that pioglitazone downregulates TGF-β1-induced MCP-1 expression in OK cells and that such effects did not depend on NF-κB activity [35] . However, our results are different from those of the study reported by Fu et al, who found that 15d-PGJ2 upregulated the expression of IL-8 in macrophages [31] . Our results suggest that different mechanisms of PPAR-γ may occur in different cell types. To date, the molecular details of the antagonizing effects of PPAR-γ on TGF-β1-induced proinflammatory cytokine expression are unclear. In our previous study [25] , we demonstrated that PPAR-γ could counteract the profibrogenic effects of TGF-β1 by downregulating the phosphorylation of Smad 2 and Smad 3. Therefore, the anti-inflammatory effects of PPAR-γ on TGF-β1-induced inflammation might target Smad signaling. However, further study is needed to fully elucidate the detailed mechanism by which this process occurs.
We demonstrated that TGF-β1 induced the expression of chemokines in tubular epithelial cells and inflammatory cells. Inflammatory cells participate in tubulointerstitial lesions by infiltrating into the tubulointerstitium mediated by the chemokine receptors on their surface. Both 15d-PGJ2 and TGL had inhibitory effects on MCP-1 and IL-8 expression. Our studies suggest that inhibiting TGF-β1−induced chemokine expression might have therapeutic effects on tubulointerstitial lesions and thus could potentially be used as a regimen for treating chronic kidney disease.
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